Live Nasdaq Composite: Stocks Slip as Oil Climbs, Big Tech Earnings Take Spotlight

Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

670 Articles

Jon C. Ogg | Jul 3, 2012 at 7:35 AM EDT

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

GlobeImmune, Inc. is the latest biotech to file for an initial public offering. Financial terms were not disclosed but the…

Jon C. Ogg | Jun 30, 2012 at 9:45 AM EDT

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…

Jon C. Ogg | May 18, 2012 at 7:47 AM EDT

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012…

Jon C. Ogg | May 10, 2012 at 12:02 PM EDT

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

It is now getting close to the middle of May, and that means one thing for biotech investors. The king…

Paul Ausick | Apr 23, 2012 at 7:59 AM EDT

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer.…

Jon C. Ogg | Mar 28, 2012 at 9:52 AM EDT

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

If there was a merger candidate which ever made sense in biotech and pharma it is Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN). …

Jon C. Ogg | Mar 23, 2012 at 8:49 AM EDT

Diabetes Drug Approved For Europe (AMLN, LLY)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) and Eli Lilly & Co. (NYSE: LLY) are in the news on the diabetes front. …

Paul Ausick | Mar 21, 2012 at 12:46 PM EDT

Dendreon Rises on Takeover Chatter (DNDN, LLY, AMGN)

AuthorDendreon Corp. (NASDAQ: DNDN), maker of prostate cancer drug Provenge, is once again rumored to be a takeover target. As…

Jon C. Ogg | Mar 16, 2012 at 6:01 AM EDT

The 10 Largest Hedge Funds in America

By now, most investors know that the large hedge funds are run by billionaires rather than millionaires. What many investors…

Paul Ausick | Feb 29, 2012 at 7:02 AM EST

FDA OKs Generic Version of Lilly Drug (LLY)

Indian drug maker Sun Pharmaceutical Industries Ltd. has received approval from the US Food and Drug Administration to sell its…

Paul Ausick | Jan 31, 2012 at 4:06 PM EST

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI number failed to…

Paul Ausick | Jan 31, 2012 at 7:24 AM EST

Lilly Earnings Dive on Patent Expiration (LLY)

Drug maker Eli Lilly & Co. reported fourth quarter and full year earnings this morning, and although revenues were higher…

Paul Ausick | Jan 5, 2012 at 8:53 AM EST

Profits to Fall Sharply at Lilly (LLY)

Profits at Eli Lilly & Co. (NYSE: LLY) in 2012 will be sharply lower than analysts had been expecting. The…

Douglas A. McIntyre | Nov 9, 2011 at 6:20 AM EST

Media Digest (11/9/2011) Reuters, WSJ, NYTimes, FT

Greece will announce its new government today. (Reuters) Inflation in China drops in October. (Reuters) Olympus investment losses may have…

Paul Ausick | Oct 20, 2011 at 10:58 AM EDT

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…

1 … 38 39 40 41 42 … 45

Eli Lilly : LLY

All Eli Lilly Articles

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

Diabetes Drug Approved For Europe (AMLN, LLY)

Dendreon Rises on Takeover Chatter (DNDN, LLY, AMGN)

The 10 Largest Hedge Funds in America

FDA OKs Generic Version of Lilly Drug (LLY)

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

Lilly Earnings Dive on Patent Expiration (LLY)

Profits to Fall Sharply at Lilly (LLY)

Media Digest (11/9/2011) Reuters, WSJ, NYTimes, FT

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Live Nasdaq Composite: Stocks Slip as Oil Climbs, Big Tech Earnings Take Spotlight

Intel Earnings Might Prove the AI Boom Is Still Going Strong — Or About to Stall

Michael Saylor’s Strategy Dilutes Shareholders Again, but Strengthens Its Reserve

Nearly Half of Retirees Left Work Earlier Than Planned. Here’s What a Forced Early Retirement Does to the Math.

Nearly Half of Retirees Left Work Earlier Than Planned. Here's What a Forced Early Retirement Does to the Math.

How Much Cash Should You Keep in Retirement? The Ramsey Team Helps A Retired Cop With $2.2 Million Saved

Price Prediction: SMCI Will Double on This Date

Wall Street Says the Chip Selloff Is a Gift: $1.1 Trillion in AI Spending Is Coming

Eli Lilly : LLY

All Eli Lilly Articles

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

Diabetes Drug Approved For Europe (AMLN, LLY)

Dendreon Rises on Takeover Chatter (DNDN, LLY, AMGN)

The 10 Largest Hedge Funds in America

FDA OKs Generic Version of Lilly Drug (LLY)

24/7 Wall St. Closing Bell (XOM, NKE, POT, TSLA, AMGN, RRC, AXE, ARMH, CE, LLY, HP, LLL, MHP, MAT, PFE, VLO, VRNG, RSH, PAY, REE, FFN)

Lilly Earnings Dive on Patent Expiration (LLY)

Profits to Fall Sharply at Lilly (LLY)

Media Digest (11/9/2011) Reuters, WSJ, NYTimes, FT

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Live Nasdaq Composite: Stocks Slip as Oil Climbs, Big Tech Earnings Take Spotlight

Intel Earnings Might Prove the AI Boom Is Still Going Strong — Or About to Stall

Michael Saylor’s Strategy Dilutes Shareholders Again, but Strengthens Its Reserve

Nearly Half of Retirees Left Work Earlier Than Planned. Here’s What a Forced Early Retirement Does to the Math.

Featured Reads

Nearly Half of Retirees Left Work Earlier Than Planned. Here's What a Forced Early Retirement Does to the Math.

How Much Cash Should You Keep in Retirement? The Ramsey Team Helps A Retired Cop With $2.2 Million Saved